Global Infertility Drugs Market - Trends, Drivers, and Challenges | Technavio

Technavio has published a new market research report on the global infertility drugs market from 2018-2022. (Graphic: Business Wire)

LONDON--()--The global infertility drugs market is expected to grow at a CAGR of close to 5% during the period 2018-2022, according to a new market research study by Technavio.

The report presents a comprehensive research of the global infertility drugs market by gender (female infertility drugs and male infertility drugs) and by therapy (hormone based therapy and other). The report also determines the geographic breakdown of the market in terms of detailed analysis and impact, which includes key geographies such as APAC, the Americas, and EMEA.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

Market driver: growing lifestyle diseases

A sedentary lifestyle is one of the major reasons for chronic conditions such as diabetes, obesity, and high blood pressure in the modern generation. Lack of physical activity and rising sedentary lifestyle is expected to affect health and become a major cause of infertility. The rise of such chronic diseases cases has turned into an epidemic and is becoming a huge concern for healthcare professionals across the globe.

According to a senior analyst at Technavio for health and wellness research, “Diabetes increases the risk of developing a number of serious health issues. High blood glucose can lead to severe health conditions which may affect the healthy sex life of both males and females.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Market trend: raising awareness regarding infertility in couples

The growing awareness about sexual health such as fertility issues across the globe is expected to act as a positive trend in the infertility treatment industry. Different government and non-government organizations across the globe are supporting couples who are facing such problems to come forward and seek professional help to tackle the problem.

For example, in the UK, National Fertility Awareness Week was celebrated from 30 October to 5 November 2017 to spread awareness, provide support, raise funds, and change the general perception about infertility. A similar campaign called the National Infertility Awareness Week was organized in Florida. Such campaigns are expected to create a positive environment for the market and will motivate more people to come forward and seek treatment.

Market challenge: rising inclination toward other modes of treatment for infertility

The increasing inclination toward other modes of treatment such as assisted reproductive technology (ART) is posing tough competition for the infertility drugs market. This trend is growing among people in developed countries, with IVF being the most commonly adopted form of ART treatment.

Is your business on track for a successful future? Learn how Technavio can help

Technavio helps businesses anticipate changes in their marketplace, make proactive adjustments, and develop effective strategies to optimize their market positions.

Big savings with Technavio this February!

Get 20% OFF on all Education Technology reports. This offer is valid only till the 28th of this month.

OR

Celebrate winter sports with 23% OFF all reports in our Outdoor Gear library (Offer valid from Feb 9-25).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The global infertility drugs market is expected to grow at a CAGR of close to 5% during the period 2018-2022, according to Technavio.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com